Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia
APML3试验结果显示，全反式维甲酸和伊达比星可用于急性早幼粒细胞白血病患者的诱导和巩固治疗初始方案。
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2011.047506
Iland, Harry; Bradstock, Ken; Seymour, John; Hertzberg, Mark; Grigg, Andrew; Taylor, Kerry; Catalano, John; Cannell, Paul; Horvath, Noemi; Deveridge, Sandra; Browett, Peter; Brighton, Tim; Chong, Li; Springall, Francisca; Ayling, Juliet; Catalano, Alberto; Supple, Shane; Collins, Marnie; Di Iulio, Juliana; Reynolds, John
